+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Forum on Vaccines and Pandemic Response · Registering as Listener

IFVPR
📅 28 – 29 Apr 2027 📍 Ephesus, Turkey 👥 Standard / Physical Participation
Listener Registration From
$165
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Forum on Vaccines and Pandemic Response
ModeStandard / Physical
ParticipationListener
Registration fee$165.00
Bank charges (5.8%)$9.57
Total payable $174.57

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 1 SDG 3 SDG 9 SDG 10

This track will explore the latest advancements in vaccine technology, including novel platforms and methodologies. Emphasis will be placed on the rapid development processes that have emerged in response to recent pandemics.

This session will focus on effective strategies for the swift deployment of vaccines during health emergencies. Discussions will include logistical challenges and innovative solutions to ensure timely access.

This track will examine the regulatory frameworks surrounding Emergency Use Authorization for vaccines. Participants will discuss the balance between expedited access and safety considerations in public health.

This session will address the critical issues of vaccine distribution and access, particularly in underserved populations. Strategies for ensuring equitable distribution during pandemics will be a focal point.

This track will highlight the importance of international collaboration in vaccine research and development. Case studies of successful partnerships during past pandemics will be discussed.

This session will explore the role of surveillance in monitoring vaccine efficacy and safety post-deployment. Participants will discuss methodologies for data collection and analysis in real-time.

This track will focus on effective containment strategies that can be employed during pandemics. The integration of vaccination efforts with other public health measures will be examined.

This session will delve into the principles of risk communication as they pertain to vaccine rollout during health crises. Best practices for engaging the public and addressing vaccine hesitancy will be discussed.

This track will assess the current state of public health preparedness in the face of potential future pandemics. Strategies for enhancing resilience through vaccination programs will be a key focus.

This session will explore the ethical dilemmas associated with vaccine distribution during pandemics. Discussions will include prioritization frameworks and the implications of access disparities.

This track will examine the long-term strategies for vaccine development and distribution in a post-pandemic world. The session will focus on lessons learned and future directions for global health initiatives.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED